Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide
A Dogan, LSP Ngu, SH Ng, PL Cervi - Leukemia, 2005 - nature.com
A Dogan, LSP Ngu, SH Ng, PL Cervi
Leukemia, 2005•nature.com3 Saxena A, Viswanathan S, Moshynska O, Tandon P, Sankaran K, Sheridan DP. Mcl-1 and
Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell
chronic lymphocytic leukemia. Am J Hematol 2004; 75: 22–33. 4 Kitada S, Andersen J, Akar
S, Zapata JM, Takayama S, Krajewski S et al. Expression of apoptosis-regulating proteins in
chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood
1998; 91: 3379–3389. 5 Johnston JB, Paul JT, Neufeld NJ, Haney N, Kropp DM, Hu X et al …
Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell
chronic lymphocytic leukemia. Am J Hematol 2004; 75: 22–33. 4 Kitada S, Andersen J, Akar
S, Zapata JM, Takayama S, Krajewski S et al. Expression of apoptosis-regulating proteins in
chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood
1998; 91: 3379–3389. 5 Johnston JB, Paul JT, Neufeld NJ, Haney N, Kropp DM, Hu X et al …
3 Saxena A, Viswanathan S, Moshynska O, Tandon P, Sankaran K, Sheridan DP. Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia. Am J Hematol 2004; 75: 22–33. 4 Kitada S, Andersen J, Akar S, Zapata JM, Takayama S, Krajewski S et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 1998; 91: 3379–3389. 5 Johnston JB, Paul JT, Neufeld NJ, Haney N, Kropp DM, Hu X et al. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia. Leukemia Lymphoma 2004; 45: 2017–2027. 6 Moshynska O, Sankaran K, Pahwa P, Saxena A. Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia. J Natl Cancer Inst 2004; 96: 673–682. 7 Tobin G, Thunberg U, Johnson A, Thorn I, Soderberg O, Hultdin M et al. Somatically mutated Ig V (H) 3–21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002; 99: 2262–2264.
nature.com